RIP-150 INTEX PHARMA
| Features | |
| Also known as | Risperdal, Rispolept |
| Blood pressure | Can cause orthostatic hypotension (a drop in blood pressure when standing up) |
| Chemical name | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one |
| Dosage (medical) | 1 to 16 mg daily, depending on condition and patient response |
| Dosage (sports) | Not applicable |
| Effects | Reduces symptoms of schizophrenia and bipolar disorder, can stabilize mood |
| Formula | C23H27FN4O2 |
| Half-life | 20 hours (parent compound), 20-30 hours (active metabolite) |
| Hepatotoxicity | Rare, but potential for liver enzyme elevations |
| Lab Test | Monitoring blood levels is not typically necessary but may be performed to check drug concentrations in specific cases |
| Main action | Dopamine and serotonin receptor antagonist |
| Raw Material | 50mg Testosterone Propionate 50mg Drostanoline Propionate 50mg Trenbolone Acetate |
| Side effects | Weight gain, extrapyramidal symptoms (such as tremors), drowsiness, dizziness, sexual dysfunction, and others |
| Storage conditions | Store at controlled room temperature, between 20 to 25В°C (68 to 77В°F) |
| Substance class | Atypical antipsychotic |
| Trade name | Risperdal, among others |
| Use in sports | None, not applicable |
| Water Retention | Minimal |
| Manufacturer | INTEX PHARMA |
| Packing | 10ml vial(150 mg/ml) |